Lv1
70 积分 2024-12-01 加入
Bispecifc BCMA/CD19 targeted CAR‑T cell therapy forces sustained disappearance of symptoms and anti‑acetylcholine receptor antibodies in refractory myasthenia gravis: a case report
7个月前
已完结
Bispecific BCMA/CD19 targeted CAR-T cell therapy forces sustained disappearance of symptoms and anti-acetylcholine receptor antibodies in refractory myasthenia gravis: a case report
7个月前
已完结
GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells
7个月前
已完结
Research progress in targeting GPRC5D for the treatment of multiple myeloma
8个月前
已完结
GPRC5D-targeted CAR T-cell therapy (CT071) in patients with relapsed or refractory multiple myeloma: a first-in-human, single-centre, single-arm, phase 1 trial
8个月前
已完结
皖公网安备34019202002308
